<p>BOSTON, Nov. 21, 2023 (GLOBE NEWSWIRE) — Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-dru
<p>Pivot</p> <p> (invalidation): 1.1905 Our preference</p> <p>Long positions above 1.1905 with targets at 1.1940 & 1.1955 in extension.</p> <p&g
<p>Bank of Japan policy board member Nakamura pushing back against speculation of any near-term change in policy from the Bak:</p><ul><li> Will need some more time before we ca
Leave a Comment